Company Name: GW Pharmaceuticals Plc

GW Pharmaceuticals Plc is a biopharmaceutical company. The company is engaged in the development/commercialization of cannabinoid medicines using its proprietary cannabinoid product platform. The company’s Sativex is approved in over 20 countries as a treatment for multiple sclerosis spasticity.

Ticker Symbol: GWPH (NASDAQ)

Company Website: www.gwpharm.com

Social Media: GW Pharmaceuticals LinkedIn

Headquarters: Cambridge, UK